Latest filing published 23 Sept 2026 for Quantum-Si Inc, €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +27.1%Entry US$0.88 · Close at T+365 US$1.12
- -17.7%Entry US$1.89 · Close at T+365 US$1.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey Alan Hawkins: trading record in brief
Filings by Jeffrey Alan Hawkins span 2 companies, the busiest being GenMark Diagnostics, Inc. and Quantum-Si Inc. We count 79 filings; the first trade dates from 3 November 2010 and the latest from 22 September 2026.
In open-market terms, that means 2 purchases worth €60k on one side and 48 sales worth €635k on the other. The net balance comes to €575k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 29 share grants. So far in 2026, the count stands at no purchases and 8 sales.
The newest entry dates from 23 September 2026: an open-market sale of €13k, in Quantum-Si Inc. The clock since the last published purchase (13 August 2024) now reads 817 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey Alan Hawkins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,143 shares@ US$0.75580.0061% mcap3.6% of flowClass A Common StockSEC:0001140361-26-037481:0
- 9,709 shares@ US$0.76080.0030% mcap1.7% of flowClass A Common StockSEC:0001140361-26-037481:1
- 11,310 shares@ US$0.95742.4% of flowClass A Common StockSEC:0001140361-26-026285:0
- 11,311 shares@ US$0.8992.3% of flowClass A Common StockSEC:0001140361-26-026285:1
- 83,712 shares@ US$1.006419.2% of flowClass A Common StockSEC:0001140361-26-016152:0
- 83,712 shares@ US$0.99519.0% of flowClass A Common StockSEC:0001140361-26-016152:1
- 12,149 shares@ US$0.82662.1% of flowClass A Common StockSEC:0001140361-26-010941:1
- 11,628 shares@ US$0.84832.3% of flowClass A Common StockSEC:0001140361-26-010941:0
- 1,305,606 shares0Class A Common StockSEC:0001140361-26-009602:0
- 23,707 shares@ US$1.2766.9% of flowClass A Common StockSEC:0001505034-25-000005:0
- 10,643 shares@ US$1.643.6% of flowClass A Common StockSEC:0001140361-25-036048:1
- 10,643 shares@ US$1.68264.1% of flowClass A Common StockSEC:0001140361-25-036048:0
- 23,705 shares@ US$1.61398.9% of flowClass A Common StockSEC:0001140361-25-023516:0
- 23,707 shares@ US$1.38558.1% of flowClass A Common StockSEC:0001140361-25-010084:0
- 1,666,666 shares0Class A Common StockSEC:0001140361-25-008848:0
- 25,000 shares@ US$0.85095.2% of flowClass A Common StockSEC:0001140361-24-036922:0Canonical exit: 7 Nov 2024 (T+90)
- 953,757 shares0Class A Common StockSEC:0001140361-24-013720:1
- 25,000 shares@ US$1.7610.8% of flowClass A Common StockSEC:0001140361-24-013720:0Canonical exit: 12 Jun 2024 (T+90)
- 440 shares@ US$9.59Common StockSEC:0001487371-15-000137:0
- 1,010 shares@ US$9.62Common StockSEC:0001487371-15-000124:0
- 367 shares@ US$9.38Common StockSEC:0001487371-15-000124:1
- 442 shares@ US$9.13Common StockSEC:0001487371-15-000098:0
- 910 shares@ US$9.50Common StockSEC:0001487371-15-000086:0
- 341 shares@ US$9.81Common StockSEC:0001487371-15-000086:1
- 5,700 shares@ US$12.06Common StockSEC:0001487371-15-000043:0
25 of 79 declarations
